報價延遲最少15分鐘:2025/05/31 11:56 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
7.96 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-4.96/-3.95
|
|
企業價值
169.47M
|
| 資產負債 |
|
每股賬面淨值
8.27
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/31 11:56 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. |